๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I clinical trial of fludarabine phosphate (F-ara-AMP)

โœ Scribed by Ephraim S. Casper; Abraham Mittelman; David Kelson; Charles W. Young

Publisher
Springer
Year
1985
Tongue
English
Weight
335 KB
Volume
15
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of fludarabine phosphate
Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer
โœ A. Mittelman; R. Ashikari; T. Ahmed; S. Savona; P. Arnold; Z. Arlin ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 181 KB

Eighteen patients with advanced breast cancer were entered into a phase II study of fludarabine phosphate. Fludarabine phosphate was given by continuous infusion for 5 days, at a starting dose of 20 mg/m2 per day for patients previously treated with two or more regimens and 25 mg/m2 per day for mini

A phase I clinical trial of immunotherap
A phase I clinical trial of immunotherapy with interferon-ฮณ gene-modified autologous melanoma cells : Monitoring the humoral immune response
โœ Zeinab Abdel-Wahab; Christina Weltz; Dina Hester; Nancy Pickett; Carol Vervaert; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 208 KB

and then 18 million for the fifth and sixth injections. The humoral immune responses of the patients were assessed by enzyme-linked immunoadsorbent assay, radioimmunoassay, and radioimmunoprecipitation. ## RESULTS. Thirteen of the 20 patients completed the immunization protocol. Eight of these 13